Abstract
Purpose: To assess the ability of genes selected from those reflecting
chromosomal instability to identify good and poor prognostic subsets of
Grade 2 breast carcinomas.
Methods: We selected genes for splitting grade 2 tumours into low
and high grade type groups by using public databases. Patients were
diagnosed between 1999–2002 at the Budai MA´ V Hospital. 187 formalinfixed,
paraffin-embedded breast cancer samples were included in the
qPCR-based measurement of expression of AURKA, FOXM1, TOP2A and
TPX2 genes. The expression of the genes were correlated to recurrencefree
survival (RFS) and immunophenotypical characterization of tumours.
1509 samples were in silico analyzed for further validation of the selected
genes.
Results: Grade 1 and 3 groups were used as training set for the selected
genes. The 4-gene signature was able to split grade 2 carcinomas
(n = 62) into a good and a poor prognosis group (RFS: 83.8±4.9 months
and 69.4±8.2 months, respectively, p = 0.016). Furthermore, independent
of grade, the identified signature containing only TOP2A and FOXM1
(TOPFOX) was able to separate ER+ tumours in an efficient manner
(p = 0.009), which is further supported by validation in a dataset containing
1509 patients (p = 8.1E-8).
Conclusions: The selected genes with the appropriately selected
control genes are able to separate the different prognostic subgroups
independently from histological grade. Our results show the feasibility of
the selection of a minimal set of genes for the development of a clinically
applicable prognostic test.
The work was partly supported by the TA´MOP.4.2.1.B-09/1/KMR-2010–
0001 grant.
Original language | English |
---|---|
Journal | European Journal of Cancer |
Volume | 47 |
Issue number | Supplement 1 |
Pages (from-to) | S180 |
ISSN | 0959-8049 |
DOIs | |
Publication status | Published - 2011 |
Event | European Multidisciplinary Cancer Congress: Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - Stockholm, Sweden Duration: 23 Sept 2011 → 27 Sept 2011 |
Conference
Conference | European Multidisciplinary Cancer Congress |
---|---|
Country/Territory | Sweden |
City | Stockholm |
Period | 23/09/2011 → 27/09/2011 |